Medytox Venture Investment logo

Medytox Venture Investment

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Medytox Venture Investment is a TIPS operator that provides opportunities and supports growth in the healthcare sector.

Investor Profile

Medytox Venture Investment has backed more than 5 startups, with 3 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in South Korea.
  • Strong thematic focus on Pharmaceutical, Biotechnology, Biopharma.

Stage Focus

  • Series B (40%)
  • Series A (40%)
  • Series C (20%)

Country Focus

  • South Korea (100%)

Industry Focus

  • Pharmaceutical
  • Biotechnology
  • Biopharma
  • Cannabis
  • Health Care
  • Clinical Trials
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Product Research
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Medytox Venture Investment frequently co-invest with?

Prologue Ventures
North America, Alabama, United States, Birmingham
Co-Investments: 1
Bilanx Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
HLB Group
Asia, Kyongsang-bukto, South Korea, Ulsan
Co-Investments: 1
E&Venture Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
BV
Asia, Seoul-t'ukpyolsi, South Korea, Yeoksamdong
Co-Investments: 1
SJ Investment Partners
North America, New York, United States, New York
Co-Investments: 1
QUAD Investment Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Donghoon Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
K2 Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Medytox Venture Investment?

Nex Eye

Seoul, Seoul-t'ukpyolsi, South Korea

Nex Eye is a start-up that develops first-in-class antibodies targeting refractory factors of immuno-oncology drugs.

MedicalOncologyPharmaceutical
Series BAug 13, 2025
Amount Raised: $44,310,374
Dime Bio

Seongnam, Kyonggi-do, South Korea

Dime Bio is a drug development company for novel dementia treatments.

MedicalPharmaceuticalTest and Measurement
Series AMar 26, 2025
Amount Raised: $8,183,930
Inventera Pharmaceuticals

Seocho, Seoul-t'ukpyolsi, South Korea

Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.

BiotechnologyPharmaceutical
Series COct 30, 2024
Amount Raised: $13,428,092
AIGEN Sciences

Seoul, Seoul-t'ukpyolsi, South Korea

AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.

Artificial Intelligence (AI)BiotechnologyPharmaceuticalProduct Research
Series AOct 16, 2024
Amount Raised: $8,794,744
NeoCannBio

Seoul, Seoul-t'ukpyolsi, South Korea

NeoCannBio offers natural product processing for natural goods and has created a hemp and medical cannabis cannabinoid library.

BiopharmaCannabisHealth Care
Series BSep 26, 2023
Amount Raised: $7,383,838
Ticaros

Seongdong, Kyonggi-do, South Korea

Ticaros is a biotech company that develops immune anti-cancer drugs.

BiotechnologyClinical TrialsPharmaceuticalTherapeutics
Series BJan 9, 2020
Amount Raised: $5,264,021

Find More Investors Like Medytox Venture Investment

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Medytox Venture Investment | Pipeseed